ORIGEN BIOMEDICAL, INC. has sponsored the creation of one or more 401k plans.
Additional information about ORIGEN BIOMEDICAL, INC.
Measure | Date | Value |
---|
2022 : ORIGEN BIOMEDICAL 401(K) PLAN 2022 401k financial data |
---|
Total income from all sources (including contributions) | 2022-12-31 | $-49,848 |
Total of all expenses incurred | 2022-12-31 | $545,302 |
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2022-12-31 | $503,167 |
Expenses. Certain deemed distributions of participant loans | 2022-12-31 | $0 |
Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2022-12-31 | $593,298 |
Value of total assets at end of year | 2022-12-31 | $3,265,313 |
Value of total assets at beginning of year | 2022-12-31 | $3,860,463 |
Total of administrative expenses incurred including professional, contract, advisory and management fees | 2022-12-31 | $42,135 |
Total interest from all sources | 2022-12-31 | $4,491 |
Total dividends received (eg from common stock, registered investment company shares) | 2022-12-31 | $0 |
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2022-12-31 | No |
Total dividends received from registered investment company shares (eg mutual funds) | 2022-12-31 | $0 |
Was this plan covered by a fidelity bond | 2022-12-31 | Yes |
Value of fidelity bond cover | 2022-12-31 | $386,046 |
If this is an individual account plan, was there a blackout period | 2022-12-31 | No |
Were there any nonexempt tranactions with any party-in-interest | 2022-12-31 | No |
Contributions received from participants | 2022-12-31 | $317,846 |
Participant contributions at end of year | 2022-12-31 | $115,854 |
Participant contributions at beginning of year | 2022-12-31 | $77,356 |
Participant contributions at end of year | 2022-12-31 | $0 |
Income. Received or receivable in cash from other sources (including rollovers) | 2022-12-31 | $65,857 |
Value of other receiveables (less allowance for doubtful accounts) at end of year | 2022-12-31 | $0 |
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2022-12-31 | No |
Value of net income/loss | 2022-12-31 | $-595,150 |
Value of net assets at end of year (total assets less liabilities) | 2022-12-31 | $3,265,313 |
Value of net assets at beginning of year (total assets less liabilities) | 2022-12-31 | $3,860,463 |
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2022-12-31 | No |
Were any loans by the plan or fixed income obligations due to the plan in default | 2022-12-31 | No |
Were any leases to which the plan was party in default or uncollectible | 2022-12-31 | No |
Investment advisory and management fees | 2022-12-31 | $42,135 |
Value of interest in registered invesment companies (eg mutual funds) at end of year | 2022-12-31 | $3,149,459 |
Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2022-12-31 | $0 |
Value of interest in pooled separate accounts at end of year | 2022-12-31 | $0 |
Value of interest in pooled separate accounts at beginning of year | 2022-12-31 | $3,783,107 |
Interest on participant loans | 2022-12-31 | $4,491 |
Interest earned from interest bearing cash (including money market accounts and certificates of deposit) | 2022-12-31 | $0 |
Expenses. Payments to insurance carriers foe the provision of benefits | 2022-12-31 | $0 |
Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2022-12-31 | $-647,637 |
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2022-12-31 | No |
Was there a failure to transmit to the plan any participant contributions | 2022-12-31 | No |
Has the plan failed to provide any benefit when due under the plan | 2022-12-31 | No |
Contributions received in cash from employer | 2022-12-31 | $209,595 |
Employer contributions (assets) at end of year | 2022-12-31 | $0 |
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2022-12-31 | $503,167 |
Did the plan have assets held for investment | 2022-12-31 | Yes |
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2022-12-31 | No |
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2022-12-31 | No |
Opinion of an independent qualified public accountant for this plan | 2022-12-31 | Unqualified |
Accountancy firm name | 2022-12-31 | PRICEKUBECKA, PLLC |
Accountancy firm EIN | 2022-12-31 | 752783674 |
2021 : ORIGEN BIOMEDICAL 401(K) PLAN 2021 401k financial data |
---|
Total income from all sources (including contributions) | 2021-12-31 | $1,076,173 |
Total of all expenses incurred | 2021-12-31 | $301,325 |
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2021-12-31 | $254,812 |
Expenses. Certain deemed distributions of participant loans | 2021-12-31 | $444 |
Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2021-12-31 | $556,850 |
Value of total assets at end of year | 2021-12-31 | $3,860,463 |
Value of total assets at beginning of year | 2021-12-31 | $3,085,615 |
Total of administrative expenses incurred including professional, contract, advisory and management fees | 2021-12-31 | $46,069 |
Total interest from all sources | 2021-12-31 | $3,179 |
Total dividends received (eg from common stock, registered investment company shares) | 2021-12-31 | $0 |
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2021-12-31 | No |
Total dividends received from registered investment company shares (eg mutual funds) | 2021-12-31 | $0 |
Was this plan covered by a fidelity bond | 2021-12-31 | Yes |
Value of fidelity bond cover | 2021-12-31 | $330,000 |
If this is an individual account plan, was there a blackout period | 2021-12-31 | No |
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities | 2021-12-31 | $0 |
Were there any nonexempt tranactions with any party-in-interest | 2021-12-31 | No |
Contributions received from participants | 2021-12-31 | $311,868 |
Participant contributions at end of year | 2021-12-31 | $77,356 |
Participant contributions at beginning of year | 2021-12-31 | $31,810 |
Participant contributions at end of year | 2021-12-31 | $0 |
Income. Received or receivable in cash from other sources (including rollovers) | 2021-12-31 | $42,074 |
Value of other receiveables (less allowance for doubtful accounts) at end of year | 2021-12-31 | $0 |
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2021-12-31 | No |
Value of net income/loss | 2021-12-31 | $774,848 |
Value of net assets at end of year (total assets less liabilities) | 2021-12-31 | $3,860,463 |
Value of net assets at beginning of year (total assets less liabilities) | 2021-12-31 | $3,085,615 |
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2021-12-31 | No |
Were any loans by the plan or fixed income obligations due to the plan in default | 2021-12-31 | No |
Were any leases to which the plan was party in default or uncollectible | 2021-12-31 | No |
Investment advisory and management fees | 2021-12-31 | $46,069 |
Value of interest in pooled separate accounts at end of year | 2021-12-31 | $3,783,107 |
Value of interest in pooled separate accounts at beginning of year | 2021-12-31 | $3,053,805 |
Interest on participant loans | 2021-12-31 | $3,179 |
Interest earned from interest bearing cash (including money market accounts and certificates of deposit) | 2021-12-31 | $0 |
Expenses. Payments to insurance carriers foe the provision of benefits | 2021-12-31 | $0 |
Net investment gain/loss from pooled separate accounts | 2021-12-31 | $516,144 |
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2021-12-31 | No |
Was there a failure to transmit to the plan any participant contributions | 2021-12-31 | No |
Has the plan failed to provide any benefit when due under the plan | 2021-12-31 | No |
Contributions received in cash from employer | 2021-12-31 | $202,908 |
Employer contributions (assets) at end of year | 2021-12-31 | $0 |
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2021-12-31 | $254,812 |
Did the plan have assets held for investment | 2021-12-31 | Yes |
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2021-12-31 | No |
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2021-12-31 | No |
Opinion of an independent qualified public accountant for this plan | 2021-12-31 | Unqualified |
Accountancy firm name | 2021-12-31 | PRICEKUBECKA, PLLC |
Accountancy firm EIN | 2021-12-31 | 752783674 |